TY - JOUR
T1 - Trinucleotide repeat length variation in the human ribosomal protein L14 gene (RPL14)
T2 - Localization to 3p21.3 and loss of heterozygosity in lung and oral cancers
AU - Shriver, Sharon P.
AU - Shriver, Mark D.
AU - Tirpak, Dayna L.
AU - Bloch, Lillian M.
AU - Hunt, Jay D.
AU - Ferrell, Robert E.
AU - Siegfried, Jill M.
N1 - Funding Information:
The authors wish to thank Dr. Jennifer Grandis for SCCHN RNA samples, and Autumn Gaither Davis and Amy Marcini for excellent technical assistance. This work was supported by IRG-58-34 from the American Cancer Society to S.P.S. and SPORE in lung cancer (NIH) P20 CA58235 to J.M.S.
PY - 1998/11
Y1 - 1998/11
N2 - Chromosome 3p is consistently deleted in lung cancer, oral squamous cell carcinoma, and renal cell carcinoma, and is believed to contain several tumor suppressor genes. We have shown a role for chromosome 3 in tumor suppression by microcell-mediated chromosome transfer experiments. We have isolated a gene that is located at 3p21.3 within the smallest region of deletion overlap in lung tumors and is the human homolog of the ribosomal protein L14 gene (RPL14). The RPL14 sequence contains a highly polymorphic trinucleotide repeat array which encodes a variable-length polyalanine tract. Genotype analysis of RPL14 shows that this locus is 68% heterozygous in the normal population, compared with 25% in non-small cell lung cancer (NSCLC) cell lines (p = 0.008). Cell cultures derived from normal bronchial epithelium show a 65% level of heterozygosity, reflecting that of the normal population. Squamous cell carcinoma of the head and neck (SCCHN), which has the same risk factors as lung cancer and is hypothesized to have a similar etiology, demonstrates 54% loss of heterozygosity at the RNA level, suggesting that transcriptional loss may be a primary mechanism of RPL14 alteration in SCCHN. In addition, RPL14 shows significant differences in allele frequency distribution in ethnically-defined populations, making this sequence a useful marker for the study of ethnicity-adjusted lung cancer risk.
AB - Chromosome 3p is consistently deleted in lung cancer, oral squamous cell carcinoma, and renal cell carcinoma, and is believed to contain several tumor suppressor genes. We have shown a role for chromosome 3 in tumor suppression by microcell-mediated chromosome transfer experiments. We have isolated a gene that is located at 3p21.3 within the smallest region of deletion overlap in lung tumors and is the human homolog of the ribosomal protein L14 gene (RPL14). The RPL14 sequence contains a highly polymorphic trinucleotide repeat array which encodes a variable-length polyalanine tract. Genotype analysis of RPL14 shows that this locus is 68% heterozygous in the normal population, compared with 25% in non-small cell lung cancer (NSCLC) cell lines (p = 0.008). Cell cultures derived from normal bronchial epithelium show a 65% level of heterozygosity, reflecting that of the normal population. Squamous cell carcinoma of the head and neck (SCCHN), which has the same risk factors as lung cancer and is hypothesized to have a similar etiology, demonstrates 54% loss of heterozygosity at the RNA level, suggesting that transcriptional loss may be a primary mechanism of RPL14 alteration in SCCHN. In addition, RPL14 shows significant differences in allele frequency distribution in ethnically-defined populations, making this sequence a useful marker for the study of ethnicity-adjusted lung cancer risk.
UR - http://www.scopus.com/inward/record.url?scp=0004949475&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0004949475&partnerID=8YFLogxK
U2 - 10.1016/S1383-5726(98)00006-5
DO - 10.1016/S1383-5726(98)00006-5
M3 - Article
C2 - 9920051
AN - SCOPUS:0004949475
SN - 1383-5726
VL - 406
SP - 9
EP - 23
JO - Mutation Research - Mutation Research Genomics
JF - Mutation Research - Mutation Research Genomics
IS - 1
ER -